EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection

Xiaodi Yang, Ye Shen, Bo Tang, Jialin Zhu, Bingjie Wang, Qingyun Wang, Wenmin Tian, Stefan Wuchty, Ziding Zhang, Zeyin Liang, Yujun Dong

Molecular & Cellular Proteomics · 2025

DOI: 10.1016/j.mcpro.2025.101068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Xiaodi Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Immunocompromised Host. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peking University First Hospital, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dysregulation of human genes and proteins following SARS-CoV-2 infection significantly impacts the clinical symptoms and prognosis of COVID-19, particularly in immunocompromised individuals such as patients with hematological tumors. Despite this, a comprehensive multi-omics understanding of human host immune responses remains incomplete. Here, we conducted a multi-omics analysis of 89 peripheral blood samples (RNA sequencing) and 98 serum samples (proteome mass spectrometry) from 52 patients with COVID-19, including patients with hematological tumors and non-tumor individuals. By integrating transcriptomic, proteomic, and interactome data, we compared differentially expressed genes (DEGs) and proteins (DEPs) across infection stages and clinical outcomes to gain insights into the mechanisms of SARS-CoV-2 infection. Our analysis revealed distinct and overlapping transcriptomic and proteomic responses to SARS-CoV-2 infection. DEGs were predominantly associated with innate immune responses and viral processes, while DEPs were linked to actin cytoskeleton organization and protein kinase regulation. Notably, DEGs and DEPs often exhibited opposing regulatory patterns, suggesting post-transcriptional and post-translational mechanisms. Tumor patients showed more severe proteomic perturbations, with a higher proportion of DEPs functioning as key hub proteins in cellular networks. Network-based drug repositioning identified potential therapeutic targets, including HSPA8, SRC, STAT1, APOE, and APP. Clinical analysis indicated that patients with long COVID experienced more severe coagulation abnormalities, immunosuppression, and myocardial injury, while acutely deceased patients exhibited abnormally activated immune responses. Our study provides a comprehensive resource for understanding the molecular mechanisms of SARS-CoV-2 infection in patients with hematological tumors. By integrating multi-omics data, we highlight the importance of proteomic changes in disease progression and identify potential therapeutic targets for COVID-19 and long COVID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Immunocompromised HostHumansProteomicsFemaleMaleMiddle AgedTranscriptomeProteomeProtein Interaction MapsAgedHematologic NeoplasmsAdultMultiomics

Stichwörter der Autor:innen

SARS-CoV-2 infectionhematological malignanciesinteractomeproteometranscriptome

Substanzen

Proteome

Autor:innen und Institutionen

  • Department of Hematology, Peking University First Hospital, Beijing, China.
  • Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
  • Department of Computer Science, University of Miami, Miami, Florida, USA; Department of Biology, University of Miami, Miami, Florida, USA; Institute of Data Science and Computation, University of Miami, Miami, Florida,…
  • College of Biological Sciences, China Agricultural University, Beijing, China.
  • Department of Hematology, Peking University First Hospital, Beijing, China. Electronic address: walzyaw@163.com.
  • Department of Hematology, Peking University First Hospital, Beijing, China. Electronic address: dongy@hsc.pku.edu.cn.

Förderung

  • Peking University First Hospital
  • Beijing Natural Science Foundation

Zitieren

APA

Yang, X., Shen, Y., Tang, B., Zhu, J., Wang, B., Wang, Q., Tian, W., Wuchty, S., Zhang, Z., Liang, Z., & Dong, Y. (2025). Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101068

Vancouver

Yang X, Shen Y, Tang B, Zhu J, Wang B, Wang Q, et al. Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101068

BibTeX
@article{Yang2025,
  author = {Yang, Xiaodi and Shen, Ye and Tang, Bo and Zhu, Jialin and Wang, Bingjie and Wang, Qingyun and Tian, Wenmin and Wuchty, Stefan and Zhang, Ziding and Liang, Zeyin and Dong, Yujun},
  title = {Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection},
  journal = {Molecular & Cellular Proteomics},
  year = {2025},
  doi = {10.1016/j.mcpro.2025.101068}
}
Kostenlos starten →